Biontech to establish regional headquarters for south east asia and first mrna manufacturing facility in singapore

Mainz, germany, may 10, 2021 — biontech se (nasdaq: bntx, “biontech” or “the company”) today announced plans to expand its global footprint to asia with the establishment of its regional headquarters for south east asia in singapore. in addition to selecting singapore as its future regional headquarters, biontech plans to establish a fully integrated mrna manufacturing facility in singapore with support from the singapore economic development board. the new facility will provide regional and global supply capacity of biontech's growing pipeline of mrna-based product candidates, as well as a rapid response production capability for south east asia to address potential pandemic threats.
BNTX Ratings Summary
BNTX Quant Ranking